Roffman Miller Associates’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15M Sell
54,271
-1,028
-2% -$290K 0.78% 43
2026
Q1
$14.8M Sell
55,299
-4,145
-7% -$1.15M 0.85% 41
2025
Q4
$16.4M Sell
59,444
-6,532
-10% -$1.83M 0.89% 39
2025
Q3
$19M Buy
65,976
+738
+1% +$218K 1.07% 32
2025
Q2
$21.6M Buy
65,238
+4,364
+7% +$1.41M 1.29% 32
2025
Q1
$20M Buy
60,874
+8,442
+16% +$2.54M 1.26% 33
2024
Q4
$14.5M Buy
52,432
+7,066
+16% +$2.25M 0.89% 40
2024
Q3
$15.7M Buy
45,366
+43,645
+2,536% +$15M 0.96% 40
2024
Q2
$569K Buy
+1,721
New +$593K 0.04% 70
2023
Q3
Sell
-29
Closed -$8.17K 100
2023
Q2
$8.17K Buy
+29
New +$7.55K ﹤0.01% 113

Other funds holding CI

Roffman Miller Associates's CI Position: Q2 2026 in Review

Roffman Miller Associates reduced its Cigna (CI) stake by 1.9% in Q2 2026, selling an estimated $290K and leaving 54,271 shares worth $15M. The position accounts for 0.78% of the portfolio, ranked #43.

Roffman Miller Associates first reported a position in CI in Q2 2023 and has held it in 10 quarters since. The position peaked at $21.6M in Q2 2025. 476 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Roffman Miller Associates held 54,271 shares of Cigna worth $15M as of Q2 2026.
  • Roffman Miller Associates sold 1,028 Cigna shares in Q2 2026, an estimated $290K.
  • Cigna made up 0.78% of Roffman Miller Associates's portfolio in Q2 2026, its #43 holding.
  • Roffman Miller Associates first reported a position in Cigna in Q2 2023 and has held it in 10 quarters since.
  • Roffman Miller Associates's Cigna position peaked at $21.6M in Q2 2025.
  • 476 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Roffman Miller Associates's 13F filing for Q2 2026, filed 13 Jul 2026.